We also demonstrated that high-expression of Tspan32 significantly prevented BCR-ABL induced B-ALL and high expression levels of TSPAN32 correlated strongly with higher overall survival probability in Ph+ B-ALL patients (Fig. 6 and Supplementary Fig. 3a). This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.